Related Experiment Video
Updated: Jul 28, 2026

Seven Steps to Stellate Cells
Published on: May 10, 2011
Identification of Liver Fibrosis-Related MicroRNAs in Human Primary Hepatic Stellate Cells Using High-Throughput
Xu Liu1,2, Heming Ma1,2, Ruihong Wu1
1Department of Hepatology, First Hospital of Jilin University, Changchun 130021, China.
Abstract:
MicroRNAs (miRNAs) participate in hepatic stellate cell (HSC) activation, which drives liver fibrosis initiation and progression. We aimed to identify novel hepatic fibrosis targets using miRNA sequencing (miRNA-seq) of human primary HSCs. Surgically resected liver tissues were used to extract HSCs. Based on next-generation sequencing, miRNA-seq was performed on four pairs of HSCs before and after in vitro culture. Additionally, we compared our data with open access miRNA-seq data derived from fourteen cirrhotic and nine healthy liver tissues. Selected miRNAs associated with fibrosis were verified by quantitative real-time PCR. Target mRNAs of differentially expressed (DE) miRNAs were predicted to construct co-expression networks. We identified 230 DEmiRNAs (118 upregulated and 112 downregulated) upon HSC activation. Of the 17 miRNAs with the most significant differences in expression, liver disease-related miRNAs included miR-758-3p, miR-493-5p, miR-409-3p, miR-31-5p, miR-1268a, and miR-381-3p, which might play roles in hepatic fibrosis. Moreover, let-7g-5p, miR-107, miR-122-5p, miR-127-3p, miR-139-5p, miR-148a-3p, miR-194-5p, miR-215-5p, miR-26a-5p, miR-340-5p, miR-451a, and miR-99a-5p were common between our data and the publicly available sequencing data. A co-expression network comprising 1891 matched miRNA-mRNA pairs representing 138 DEmiRNAs and 1414 DEmRNAs was constructed. MiR-1268a and miR-665, possessing the richest target DEmRNAs, may be vital in HSC activation. The targeted genes were involved in collagen metabolism, extracellular matrix structural constituent, cytoskeletal protein binding, and cell adhesion. The miRNAs we identified may provide a basis and reference for the selection of diagnostic and therapeutic targets for hepatic fibrosis.
Insights
This study identifies key microRNAs (miRNAs) involved in liver fibrosis by analyzing hepatic stellate cell (HSC) activation. These findings offer potential diagnostic and therapeutic targets for liver disease.
Area of Science:
- Molecular Biology
- Hepatology
- Genomics
Background:
- MicroRNAs (miRNAs) are crucial regulators of hepatic stellate cell (HSC) activation, a key process in liver fibrosis.
- Understanding miRNA involvement in HSC activation is vital for developing targeted therapies for liver fibrosis.
Purpose of the Study:
- To identify novel microRNA (miRNA) targets involved in hepatic fibrosis through miRNA sequencing (miRNA-seq) of human primary hepatic stellate cells (HSCs).
- To explore the role of differentially expressed miRNAs and their mRNA targets in the pathogenesis of liver fibrosis.
Main Methods:
- miRNA sequencing (miRNA-seq) was performed on human primary HSCs before and after in vitro activation.
- Data was compared with publicly available miRNA-seq data from cirrhotic and healthy liver tissues.
- Quantitative real-time PCR validated selected miRNAs, and co-expression networks were constructed to identify miRNA-mRNA interactions.
Main Results:
- 230 differentially expressed miRNAs (DEmiRNAs) were identified during HSC activation.
- Several liver disease-related miRNAs, including miR-758-3p, miR-493-5p, miR-409-3p, miR-31-5p, miR-1268a, and miR-381-3p, were highlighted.
- A co-expression network revealed miR-1268a and miR-665 as potentially vital in HSC activation, with targeted genes involved in collagen metabolism and cell adhesion.
Conclusions:
- The study identified a set of differentially expressed miRNAs and their target genes implicated in hepatic fibrosis.
- Specific miRNAs, such as miR-1268a and miR-665, show significant potential as diagnostic and therapeutic targets for liver fibrosis.
- These findings provide a foundation for future research into miRNA-based interventions for liver fibrosis.

